Healthcare / Medical - Equipment & ServicesUpdated 2026-05-10 22:07 UTC

LON/0HRS stock hub

LON/0HRS has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0HRSis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

84.8B

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0HRS

In the news

Latest news · LON/0HRS

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E11.9

P25 12.9P50 16.9P75 23.5

Trailing P/E38.2

P25 15.9P50 22.9P75 35.8

ROE3.8

P25 -54.2P50 2.1P75 13.7

ROIC6.3

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0HRS market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

233

Groups with data

Currency

USD

Showing 233 of 233 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	UK
Employees	300,000
Employees Change	0%
Employees Change Percent	0
Enterprise value	$133.8B
Exchange	London Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Medical - Equipment & Services
Isin	US1266501006
Last refreshed	2026-05-10
Market cap	$84.8B
Price	$89.29
Price currency	USD
Rev Per Employee	1,183,724.62x
Sector	Healthcare
Sic	8000
Symbol	lon/0HRS
Website	https://www.cvshealth.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.62%
EV Earnings	60.24x
EV/EBIT	16.81x
EV/EBITDA	9.89x
EV/FCF	23.89x
EV/Sales	0.45x
FCF yield	6.6%
Forward P/E	11.86x
P/B ratio	1.44x
P/E ratio	38.19x
P/S ratio	0.28x
PE Ratio10 Y	23.11x
PE Ratio3 Y	36x
PE Ratio5 Y	30x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	2.67%
EBITDA Margin	3.8%
FCF margin	1.82%
Gross margin	13.39%
Gross Profit	$41.1B
Gross Profit Growth	6.44%
Gross Profit Growth Q	8.46%
Gross Profit Growth3 Y	0.51%
Gross Profit Growth5 Y	2.25%
Net Income	$2.2B
Net Income Growth	-44.47%
Net Income Growth Q	65.43%
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Net Income Growth3 Y	-10.52%
Net Income Growth5 Y	-16.89%
Pretax Margin	0.85%
Profit Margin	0.72%
Profit Per Employee	$8,557
Profitable Years	7
ROA	2.67
Roa5y	3.25
ROCE	6.51
ROE	3.75
Roe5y	7.3
ROIC	6.3
Roic5y	6.76

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	39.72%
Cagr3y	12.49%
Cagr5y	4.34%
Div CAGR3	0.94%
Div CAGR5	5.69%
EPS Growth	-45.23
EPS Growth Q	63.12
EPS Growth Quarters	1
EPS Growth Years	0
EPS Growth3 Y	-9.68
EPS Growth5 Y	-16.38
FCF Growth	24.46%
FCF Growth Q	-10.83%
FCF Growth3 Y	-24.81%
FCF Growth5 Y	-10.57%
OCF Growth	17.95%
OCF Growth Q	-6.74%
OCF Growth10 Y	1.54%
OCF Growth3 Y	-19.83%
OCF Growth5 Y	-7.73%
Revenue Growth	7.67x
Revenue Growth Q	6.15x
Revenue Growth Quarters	49x
Revenue Growth Years	13x
Revenue Growth3 Y	7.13x
Revenue Growth5 Y	8.47x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$1.6
Assets	$191.6B
Cash	$8.9B
Current Assets	$54.9B
Current Liabilities	$63.4B
Debt	$59.3B
Debt EBITDA	$4.25
Debt Equity	$1.01
Debt FCF	$10.6
Equity	$58.8B
Interest Coverage	3.49
Liabilities	$132.8B
Long Term Assets	$136.7B
Long Term Liabilities	$69.4B
Net Cash	$-50.4B
Net Cash By Market Cap	$-59.43
Net Debt EBITDA	$4.32
Net Debt Equity	$0.86
Net Debt FCF	$9
Tangible Book Value	$-25.1B
Tangible Book Value Per Share	$-19.69
WACC	5.79

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.87
Inventory Turnover	19.99
Net Working Capital	$-14.3B
Quick ratio	0.61
Working Capital	$-8.8B
Working Capital Turnover	$-22.46

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-1.07%
Dividend Growth	-4.18%
Dividend Growth Years	0%
Dividend per share	$1.98
Dividend Years	9
Dividend Yield	2.21%
Ex Div Date	2026-04-23
Last Dividend	$0.49
Payout Frequency	Quarterly
Payout Ratio	116.1%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	39.69%
200-day SMA	76.12
3Y total return	42.35%
50-day SMA	77.48
50-day SMA vs 200-day SMA	50over200
5Y total return	23.66%
All Time High	111.1
All Time High Change	-19.66%
All Time High Date	2022-02-08
All Time Low	43.56
All Time Low Change	105.01%
All Time Low Date	2024-12-23
ATR	3.46
Beta	0.59
Ch YTD	11.91
High	89.92
High52	89.92
High52 Date	2026-05-08
High52ch	-0.36%
Low	85.41
Low52	58.5
Low52 Date	2025-05-15
Low52ch	52.63%
Ma50ch	15.24%
Price vs 200-day SMA	17.3%
RSI	74.27
RSI Monthly	61.27
RSI Weekly	65.1
Sharpe ratio	1.15x
Sortino ratio	1.78
Total Return	1.14%
Tr YTD	13.81
Tr1m	15.15%
Tr1w	8.27%
Tr3m	14.25%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$8.2B
Operating Income Growth	16.19
Operating Income Growth Q	25.09
Operating Income Growth3 Y	-10.92
Operating Income Growth5 Y	-4.45
Operating margin	2.67

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,273,329,087%
Net Borrowing	-1,243,306,230
Shares Insiders	0.1%
Shares Institutions	89.95%
Shares Qo Q	0.16%
Shares Yo Y	1.07%
Short Ratio	2.31

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$5.1B
Average Volume	3,859.8x
Bv Per Share	46.08
CAPEX	$-2.2B
Ch1m	14.15
Ch1w	8.27
Ch1y	34.78
Ch3m	13.27
Ch3y	26.76
Ch5y	4.84
Ch6m	13.48
Change	2.89%
Change From Open	2.05
Close	86.78
Days Gap	0.83
Depreciation Amortization	3,349,958,438
Dollar Volume	176,258.5
Earnings Date	2026-08-05
EBIT	$8.2B
EBITDA	$11.7B
EPS	$1.74
F Score	6
FCF	$5.6B
FCF EV Yield	4.19x
Financing CF	-3,730,484,430
Fiscal Year End	December
Founded	1,963
Goodwill	62,699,309,692
Graham Number	57.07446
Graham Upside	-36.08
Income Tax	$419.5M
Investing CF	-4,530,955,815
Is Primary Listing	0
Last Earnings Date	2026-02-04
Last Report Date	2026-03-31
Lynch Fair Value	$11.69
Lynch Upside	-86.91
Ma150	78.23
Ma150ch	14.13%
Ma20	80.26
Ma20ch	11.25%
Net CF	-436,964,985
Next Earnings Date	2026-08-05
Open	87.5
P FCF Ratio	15.14
P OCF Ratio	10.84
Payment Date	2026-05-04
Position In Range	86.03
Ppne	20,375,551,892
Price Date	2026-05-08
Price EBITDA	$7.26
Relative Volume	0.54x
Revenue	307,176,539,490x
SBC By Revenue	0.17x
Share Based Comp	511,180,875
Tax By Revenue	0.14x
Tax Rate	16.03%
Tr6m	15.4%
Volume	1,974
Z Score	2.35

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

LON/0HRS dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+2.2%

$1.98 annual per share

Payout ratio

+116.1%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+5.7%

0 consecutive years of growth

Total shareholder yield

+1.1%

Next ex-dividend date: 2026-04-23

Performance

LON/0HRS stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0HRS?

Insider, institutional, and short-interest positioning.

Institutional ownership

+90.0%

Share of float held by funds and institutions

Insider ownership

+0.1%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

LON/0HRS momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

74.3

Above 70: short-term overbought

Price vs 200-day MA

+17.3%

50/200-day relationship not available

Beta (5Y)

0.59

Less volatile than the market

Sharpe ratio

1.15

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0HRS

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0HRS stock rating?

lon/0HRS is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0HRS analysis?

The full report lives at /stocks/lon/0HRS/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0HRS?

The latest report frames lon/0HRS around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0HRS page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.